Stock 1177 SINO BIOPHARMACEUTICAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Sino Biopharmaceutical Limited

Equities

1177

KYG8167W1380

Market Closed - Hong Kong S.E.
Other stock markets
 04:09:00 2024-05-03 am EDT 		5-day change 1st Jan Change
2.87 HKD -0.35% Intraday chart for Sino Biopharmaceutical Limited +4.74% -17.29%
Apr. 30 Wall Street, Earnings, Federal Reserve Roil Asian Stock Markets MT
Apr. 30 Sino Biopharmaceutical Limited Announces Approval for Marketing of Category 1 Unecritinib Fumarate Capsules CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Nomura Adjusts Sino Biopharmaceutical’s Price Target to HK$6.16 From HK$6.63, Keeps at Buy
MT
Sino Biopharmaceutical Gets 'A' ESG Rating from MSCI
MT
Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$6.63 From HK$7.43, Keeps at Buy
MT
Nomura Adjusts Sinobiopharma's Price Target to HK$7.43 From HK$7.78, Keeps at Buy
MT
UBS Adjusts Sino Biopharmaceutical's Price Target to HK$7.5 From HK$8, Keeps at Buy
MT
Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$7.78 From HK$8.19, Keeps at Buy
MT
Nomura Adjust Sino Biopharma’s Price Target to HK$8.19 From HK$8.53, Keeps at Buy
MT
UBS Adjusts Sino Biopharmaceutical's Price Target to HK$8 From HK$11.6, Keeps at Buy
MT
Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$8.53 From HK$9.38, Keeps at Buy
MT
SINO BIOPHARMACEUTICAL : Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$9.3 From HK$8.97, Keeps at Buy
MT
Market Chatter: Hong Kong's Vaccination Rate Plunges Amid Fears of COVID-19 Jab Complications
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1177 Stock
  4. News Sino Biopharmaceutical Limited
  5. Analyst Reco.